FXG

N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide

Find entries where: FXG

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide
Identifiers	N-butyl-3-[6-(9H-purin-6-ylamino)hexanoylamino]benzamide
Formula	C₂₂ H₂₉ N₇ O₂
Molecular Weight	423.511
Type	NON-POLYMER
Isomeric SMILES	CCCCNC(=O)c1cccc(c1)NC(=O)CCCCCNc2c3c([nH]cn3)ncn2
InChI	InChI=1S/C22H29N7O2/c1-2-3-11-24-22(31)16-8-7-9-17(13-16)29-18(30)10-5-4-6-12-23-20-19-21(26-14-25-19)28-15-27-20/h7-9,13-15H,2-6,10-12H2,1H3,(H,24,31)(H,29,30)(H2,23,25,26,27,28)
InChIKey	WOYITRCGMUXUDE-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	60
Chiral Atom Count	0
Bond Count	62
Aromatic Bond Count	16

Drug Info: DrugBank

DrugBank ID	DB07801
Name	N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide
Groups	experimental
Synonyms	N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Aurora kinase A	MDRSKENCISGPVKATAPVGGPKRVLVTQQFPCQNPLPVNSGQAQRVLCP...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682